美沙酮或丁丙诺啡比纳曲酮更受囚犯青睐

Alcoholism & Drug Abuse Weekly Pub Date : 2024-09-27 DOI:10.1002/adaw.34262

Alison Knopf

{"title":"美沙酮或丁丙诺啡比纳曲酮更受囚犯青睐","authors":"Alison Knopf","doi":"10.1002/adaw.34262","DOIUrl":null,"url":null,"abstract":"When CODAC Behavioral Healthcare, the main provider of treatment services for corrections in Rhode Island, looks at its clientele with opioid use disorder (OUD), Vivitrol (depot naltrexone) is preferred by no one. The patients want either methadone or buprenorphine, CODAC CEO Linda Hurley explained in a webinar this month (for the first part of this two-part article, see ADAW (https://onlinelibrary.wiley.com/doi/10.1002/adaw.34254).","PeriodicalId":100073,"journal":{"name":"Alcoholism & Drug Abuse Weekly","volume":"36 37","pages":"1-3"},"PeriodicalIF":0.0000,"publicationDate":"2024-09-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Methadone or buprenorphine preferred over naltrexone by inmates\",\"authors\":\"Alison Knopf\",\"doi\":\"10.1002/adaw.34262\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"When CODAC Behavioral Healthcare, the main provider of treatment services for corrections in Rhode Island, looks at its clientele with opioid use disorder (OUD), Vivitrol (depot naltrexone) is preferred by no one. The patients want either methadone or buprenorphine, CODAC CEO Linda Hurley explained in a webinar this month (for the first part of this two-part article, see ADAW (https://onlinelibrary.wiley.com/doi/10.1002/adaw.34254).\",\"PeriodicalId\":100073,\"journal\":{\"name\":\"Alcoholism & Drug Abuse Weekly\",\"volume\":\"36 37\",\"pages\":\"1-3\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-09-27\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Alcoholism & Drug Abuse Weekly\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1002/adaw.34262\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Alcoholism & Drug Abuse Weekly","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/adaw.34262","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

摘要

CODAC 行为医疗保健公司是罗德岛惩戒治疗服务的主要提供商，该公司在研究其患有阿片类药物使用障碍（OUD）的客户时发现，Vivitrol（去甲纳曲酮）并不是所有人的首选。CODAC 首席执行官琳达-赫尔利（Linda Hurley）在本月的一次网络研讨会上解释说，患者需要的是美沙酮或丁丙诺啡（本文共两部分，第一部分见 ADAW (https://onlinelibrary.wiley.com/doi/10.1002/adaw.34254)）。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Methadone or buprenorphine preferred over naltrexone by inmates

When CODAC Behavioral Healthcare, the main provider of treatment services for corrections in Rhode Island, looks at its clientele with opioid use disorder (OUD), Vivitrol (depot naltrexone) is preferred by no one. The patients want either methadone or buprenorphine, CODAC CEO Linda Hurley explained in a webinar this month (for the first part of this two-part article, see ADAW (https://onlinelibrary.wiley.com/doi/10.1002/adaw.34254).

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Alcoholism & Drug Abuse Weekly

自引率

0.00%

发文量